Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, May 2000, p. 1407-1408, Vol. 44, No. 5
Department of Pathology, University of Texas
Medical Branch, Galveston, Texas 77555-06091;
Novartis Research Institute, A-1235 Vienna,
Austria2; and PE Biosystems, Foster
City, California 944043
Received 19 October 1999/Returned for modification 17 December
1999/Accepted 7 February 2000
We evaluated terbinafine and itraconazole against 30 isolates of
Penicillium marneffei using a modification of the National Committee for Clinical Laboratory Standards broth macrodilution MIC
testing protocol for yeasts. The minimal fungicidal concentration (MFC)
was determined by plating 100 µl from each MIC drug dilution having
no growth onto Sabouraud glucose agar incubated at 30°C. The MFC was
the dilution at which growth was absent at 72 h of incubation. The
MICs, in micrograms per milliliter, were as follows: terbinafine, 0.03 to 1.0 (geometric mean titer, 0.09); itraconazole, 0.03 to 0.5 (geometric mean titer, 0.04). The MFCs, in micrograms per milliliter,
were as follows: terbinafine, 0.03 to 8 (geometric mean titer, 2.60);
itraconazole, 0.03 to 8 (geometric mean titer, 2.45). Primary
fungicidal activity (MFC within 2 dilutions of MIC) was observed with
terbinafine in eight isolates and with itraconazole in four isolates.
The data indicate that terbinafine is active against P. marneffei in vitro and may have a previously unrealized role in
the management of infections caused by this fungus.
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
In Vitro Comparison of Terbinafine and Itraconazole
against Penicillium marneffei
*
Corresponding author. Mailing address: 301 University
Blvd., Galveston, TX 77555-0609. Phone: (409) 747-0604. Fax: (409)
747-0605. E-mail: michael.mcginnis{at}utmb.edu.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |